Shaanxi Meibang plans to raise fund to build capacity for chlorantraniliprole and others

On 18 July, Shaanxi Meibang Pharmaceutical Group Co., Ltd. (Shaanxi Meibang) announced it had applied for issuing convertible corporate bonds to unspecified objects to raise funds no more than USD73.45 million (RMB530 million). According to its plan,...

Insecticides China Monthly Report 202307

www.cnchemicals.com